Table 3 of Dai, Mol Vis 2016; 22:9-17.

Table 3. Comparison of genotype and allele frequencies of CFI-rs7356506 polymorphisms in VKH patients versus controls stratified by recurrence status.

Polymorphism Non-recurrent VKH (n=45) Recurrent VKH (n=27) Controls
(n=300) p-value † p -value ‡ Odds ratio (95% CI)§ Odds ratio (95% CI) ¶
CFI -rs7356506 (G/A)
Genotype
GG 4 (8.9) 1 (3.7) 34 (11.3) 0.875* 0.043*
AG 21 (46.7) 8 (29.6) 139 (46.3) 0.014** 0.364 (0.158–0.837)
AA 20 (44.4) 18 (66.7) 126 (42.4) 0.334***# 3.336 (0.439–25.373)
Allele
G 29 (32.2) 10 (18.5) 207 (34.6) 0.656* 0.016* 0.429
(0.212–0.871)
A 61 (67.8) 44 (81.5) 391 (65.4)

Data are the number of subjects (% of the total group). †p-value for patients who had non-recurrent VKH versus controls. ‡ p-value for patients who had recurrent VKH versus controls. **p-value for dominant model. ***p-value for recessive model. §OR (95% CI) for patients who had non-recurrent VKH versus controls. ¶ OR (95% CI) for patients who had recurrent VKH versus controls. *χ2 test. # Fisher exact test.

Dai, Mol Vis 2016; 22:9-17. http://www.molvis.org/molvis/v22/9

©2016 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535